| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.19 | 3e-05 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.2 | 0.0003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.18 | 0.0004 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0005 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.51 | 0.001 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.09 | 0.002 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.002 |